Abstract
Purpose
Radiation exposure (RE) is a matter of concern for patients with congenital heart disease (CHD) who not infrequently need multiple interventional procedures under fluoroscopy guidance. We sought to evaluate the safety and feasibility of a minimally fluoroscopic approach in patients with CHD undergoing catheter ablation using a new image integration module (IIM).
Methods
Consecutive patients with CHD undergoing catheter ablation using the Carto Univu™ IIM were included. A near-zero fluoroscopy procedure was defined by an effective dose (ED) ≤ 1 mSv. RE parameters (total fluoroscopy time [TFT], total dose area product [tDAP], and ED), ablation outcomes, and complications were evaluated.
Results
Fifty-five patients with CHD underwent 63 ablation procedures (supraventricular tachycardia, n = 53; ventricular tachycardia, n = 10). The CHD was simple in 25%, moderate in 42%, and complex in 33%. The use of the IIM resulted in very low levels of RE (median TFT 0.13 min [IQR 0–1.04], median tDAP 54.5 cGy cm2 [IQR 9.5–176.4], median ED 0.136 mSv [IQR 0.02–0.49]). Patients with complex CHD had significantly higher RE when compared with patients with simple and moderate defects. A total of 56/63 ablation procedures (89%) were performed with an ED ≤ 1 mSv. One patient developed sinus node dysfunction requiring pacemaker implantation.
Conclusions
The use of a minimally fluoroscopic approach was safe and feasible resulting in very low RE during catheter ablation of patients with CHD. A near-zero fluoroscopy ablation was possible in up to 89% of the procedures.
Similar content being viewed by others
References
National Research Council. Biological effects of ionizing radiation: BEIR VII phase 2. Washington, DC: National Academies Press; 2006.
Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007;168:1–64. https://doi.org/10.1667/RR0763.1.
Eisenberg MJ, Afilalo J, Lawler PR, Abrahamowicz M, Richard H, Pilote L. Cancer risk related to low-dose ionizing radiation from cardiac imaging in patients after acute myocardial infarction. CMAJ. 2011;183:430–6. https://doi.org/10.1503/cmaj.100463.
Lawler PR, Afilalo J, Eisenberg MJ, Pilote L. Comparison of cancer risk associated with low-dose ionizing radiation from cardiac imaging and therapeutic procedures after acute myocardial infarction in women versus men. Am J Cardiol. 2013;112:1545–50. https://doi.org/10.1016/j.amjcard.2013.07.009.
Gerber TC, Carr JJ, Arai AE, Dixon RL, Ferrari VA, Gomes AS, et al. Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention. Circulation. 2009;119:1056–65.
Berrington de González A, Darby S. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet. 2004;363:345–51.
Picano E. Sustainability of medical imaging. Education and debate. BMJ. 2004;328:578–80.
Mettler FA Jr, Bhargavan M, Faulkner K, Gilley DB, Gray JE, Ibbott GS, et al. Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other radiation sources 1950-2007. Radiology. 2009;253:520–31.
Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014;11:e102–65.
Ferguson JD, Helms A, Mangrum JM, Mahapatra S, Mason P, Bilchick K, et al. Catheter ablation of atrial fibrillation without fluoroscopy using intracardiac echocardiography and electroanatomic mapping. Circ Arrhythm Electrophysiol. 2009;2:611–9.
Caponi D, Corleto A, Scaglione M, Blandino A, Biasco L, Cristoforetti Y, et al. Ablation of atrial fibrillation: does the addition of three-dimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome?: a randomized comparison of Carto-Merge vs. Carto-xp three-dimensional mapping ablation in patients with paroxysmal and persistent atrial fibrillation. Europace. 2010;12:1098–104.
Casella M, Dello Russo A, Pelargonio G, Del Greco M, Zingarini G, Piacenti M, et al. Near zerO fluoroscopic exPosure during catheter ablAtion of supRavenTricular arrhYthmias: the NO-PARTY multicentre randomized trial. Europace. 2016;18:1565–72.
Sporton SC, Earley MJ, Nathan AW, Schilling RJ. Electroanatomic versus fluoroscopic mapping for catheter ablation procedures: a prospective randomized study. J Cardiovasc Electrophysiol. 2004;15:310–5.
Ferguson JD, Helms A, Mangrum JM, Mahapatra S, Mason P, Bilchick K, et al. Catheter ablation of atrial fibrillation without fluoroscopy using intracardiac echocardiography and electroanatomic mapping. Circ Arrhythm Electrophysiol. 2009;2:611–9.
Cano Ó, Alonso P, Osca J, Andrés A, Sancho-Tello MJ, Olagüe J, et al. Initial experience with a new image integration module designed for reducing radiation exposure during electrophysiological ablation procedures. J Cardiovasc Electrophysiol. 2015;26:662–70.
Cano Ó, Andrés A, Osca J, Alonso P, Sancho-Tello MJ, Olagüe J, et al. Safety and feasibility of a minimally fluoroscopic approach for ventricular tachycardia ablation in patients with structural heart disease: influence of the ventricular tachycardia substrate. Circ Arrhythm Electrophysiol. 2016;9:e003706.
Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA2008 guidelines for the management of adults with congenital heart disease: executive summary. J Am Coll Cardiol. 2008;52:1890–947.
Ghelani SJ, Glatz AC, David S, Leahy R, Hirsch R, Armsby LB, et al. Radiation dose benchmarks during cardiac catheterization for congenital heart disease in the United States. JACC Cardiovasc Interv. 2014;7:1060–9.
Beauséjour Ladouceur V, Lawler PR, Gurvitz M, Pilote L, Eisenberg MJ, Ionescu-Ittu R, et al. Exposure to low-dose ionizing radiation from cardiac procedures in patients with congenital heart disease: 15-year data from a population-based longitudinal cohort. Circulation. 2016;133:12–20.
Mathews JD, Forsythe AV, Brady Z, Butler MW, Goergen SK, Byrnes GB, et al. Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ. 2013;346:f2360.
Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. 2009;169:2078–86.
Heidbuchel H, Wittkampf F, Vano E, Ernst S, Schilling R, Picano E, et al. Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedures. Europace. 2014;16:946–64.
Einstein AJ, Weiner SD, Bernheim A, Kulon M, Bokhari S, Johnson LL, et al. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. JAMA. 2010;304:2137–44.
El-Sayed T, Patel AS, Cho JS, Kelly JA, Ludwinski FE, Saha P, et al. Radiation-induced DNA damage in operators performing endovascular aortic repair. Circulation. 2017;136:2406–16.
Christoph M, Wunderlich C, Moebius S, Forkmann M, Sitzy J, Salmas J, et al. Fluoroscopy integrated 3D mapping significantly reduces radiation exposure during ablation for a wide spectrum of cardiac arrhythmias. Europace. 2015;17:928–37.
Huo Y, Christoph M, Forkmann M, Pohl M, Mayer J, Salmas J, et al. Reduction of radiation exposure during atrial fibrillation ablation using a novel fluoroscopy image integrated 3-dimensional electroanatomic mapping system: a prospective, randomized, single-blind, and controlled study. Heart Rhythm. 2015;12:1945–55.
Klehs S, Schneider HE, Backhoff D, Paul T, Krause U. Radiofrequency catheter ablation of atrial tachycardias in congenital heart disease: results with special reference to complexity of underlying anatomy. Circ Arrhythm Electrophysiol. 2017;10:e005451. https://doi.org/10.1161/CIRCEP.117.005451.
Ueda A, Suman-Horduna I, Mantziari L, Gujic M, Marchese P, Ho SY, et al. Contemporary outcomes of supraventricular tachycardia ablation in congenital heart disease: a single-center experience in 116 patients. Circ Arrhythm Electrophysiol. 2013;6:606–13.
Acknowledgments
The authors would like to thank the nurse team of our Electrophysiology Laboratory (Ana García Orts, Samuel Reina de la Torre and Sonia Jiménez Cordero) for their help with patient management and acquisition of the data. We would also like to thank Elena Pérez Rafels, Gloria Pastor, and Jorge Barber from Biosense Webster for their technical assistance during the cases and during elaboration of manuscript figures.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Cano has received consultant fees from Biosense Webster. All other authors have nothing to disclose.
Ethical approval and informed consent
All patients signed an informed cosent and the study protocol was approved by the local ethical comittee of the Hospital Universitari i Politècnic La Fe.
Rights and permissions
About this article
Cite this article
Cano, Ó., Saurí, A., Plaza, D. et al. Evaluation of a near-zero fluoroscopic approach for catheter ablation in patients with congenital heart disease. J Interv Card Electrophysiol 56, 259–269 (2019). https://doi.org/10.1007/s10840-018-0467-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-018-0467-3